IDIX Key Stats
- IDENIX PHARMACEUTICALS INC Financials Yahoo 03/06 13:04 ET
- Nasdaq stocks posting largest percentage decreases Yahoo 03/05 18:03 ET
- Idenix Q4 Loss Narrower-Than-Expected - Analyst Blog Zacks 02/28 14:39 ET
- Idenix Q4 Loss Narrower-Than-Expected Yahoo 02/28 13:39 ET
- IDENIX PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements an Yahoo 02/27 18:42 ET
- Idenix Pharma (IDIX) Files $200M Mixed Shelf Street Insider 02/27 16:40 ET
- Idenix Pharmaceuticals Reports Fourth Quarter and Year Ended 2013 Financial Results noodls 02/27 16:36 ET
- IDENIX PHARMACEUTICALS INC Files SEC form 10-K, Annual Report Yahoo 02/27 16:32 ET
- Idenix Pharmaceuticals (IDIX) Tops Q4 EPS by 5c Street Insider 02/27 16:15 ET
- Idenix Pharmaceuticals to Present at Two Upcoming Healthcare Conferences noodls 02/26 09:38 ET
IDIX Total Returns Comparison
This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Idenix Pharmaceuticals is up 45.08% over the last year vs S&P 500 Total Return up 24.21%, Actelion up 98.29%, and United Therapeutics up 64.62%.
Income Statement View Statement
Balance Sheet View Statement
Pro Ratings for IDIX
Pro Report PDF for IDIX
Download Pro Ratings, Key Stats, Performance Charts, Valuations, and Financials in an easy to print format.Download IDIX Pro Report PDF
Pro Strategies Featuring IDIX
Did Idenix Pharmaceuticals make it into our Pro Portfolio Strategies?
Start your YCharts Pro membership now to find out.
- Sector: Healthcare
- Industry: Biotechnology
- Headquarters Country: United States
- Headquarters State/Province: Massachusetts
- Incorporation Country: United States
- Incorporation State/Province: Delaware
Idenix Pharmaceuticals, Inc. is a biopharmaceutical company engaged in the discovery and development of drugs for the treatment of human viral diseases with operations in the United States and Europe.